PT-141 10 mg (bremelanotide) is a synthetic melanocortin receptor agonist research compound supplied for laboratory research only. It is studied in models of central melanocortin signalling.
Mechanism of Central Nervous System Activation
PT-141 is a non-selective agonist of the melanocortin receptors, particularly MC3 and MC4 in the brain. Unlike compounds that act on the vascular system, it is studied for its activity in the hypothalamus and other central pathways.
Applications in Research
PT-141 is a reference compound in research on melanocortin pathways, including arousal-related signalling, mood and energy regulation, and metabolic control in laboratory models.
Background
PT-141 was discovered during research on Melanotan II, a related melanocortin analogue. It shares the parent structure but has a distinct receptor profile, and it has since been studied as a standalone compound.
Handling, Stability and Storage
This 10 mg vial is produced using high-purity synthesis to support consistent research results. It is supplied lyophilised (freeze-dried) to maintain molecular stability in transit. Store in a cool, dark place or refrigerate at 2°C to 8°C. Once reconstituted with bacteriostatic water, keep the solution chilled and use it within the recommended laboratory timeframe.
For laboratory and research purposes only. Not for human consumption, medical use, or veterinary use.
